0000899243-21-013804.txt : 20210329
0000899243-21-013804.hdr.sgml : 20210329
20210329163013
ACCESSION NUMBER: 0000899243-21-013804
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210325
FILED AS OF DATE: 20210329
DATE AS OF CHANGE: 20210329
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bazemore Robert B
CENTRAL INDEX KEY: 0001620152
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35945
FILM NUMBER: 21782023
MAIL ADDRESS:
STREET 1: 33 HAYDEN AVE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Epizyme, Inc.
CENTRAL INDEX KEY: 0001571498
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261349956
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 TECHNOLOGY SQUARE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-229-5872
MAIL ADDRESS:
STREET 1: 400 TECHNOLOGY SQUARE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-25
0
0001571498
Epizyme, Inc.
EPZM
0001620152
Bazemore Robert B
C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
1
1
0
0
President & CEO
Common Stock, par value $0.0001
2021-03-25
4
S
0
10328
7.85
D
322626
D
Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted under the Issuer's 2013 Stock Incentive Plan on March 24, 2020. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the reporting person.
The Reporting Person acquired 977 shares of common stock under the Issuer's 2013 Employee Stock Purchase Plan on February 28, 2021.
/s/ John Weidenbruch, attorney-in-fact
2021-03-29